Novartis | NVS - PE Price to Earnings



Novartis reported 18.97 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
AbbVie 18.41 69.26 Jun/2025
Amgen 12.51 28.7 Jun/2025
AstraZeneca 20.04 12.31 Jun/2025
Bausch Health Companies 11.37 2.38 Jun/2025
Biogen 12.41 0.17 Jun/2025
Bristol-Myers Squibb 17.27 3.22 Jun/2025
Corcept Therapeutics 63.83 34.36 Jun/2025
Drreddys Laboratories 18.95 1.5 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Gilead Sciences 15.39 279.48 Jun/2025
GlaxoSmithKline GBP 18.27 5.23 Jun/2025
Glaxosmithkline 18.39 3.81 Jun/2025
J&J 19.02 9.62 Jun/2025
Merck 8.58 4.74 Jun/2025
Novartis 15.89 3.03 Jun/2025
Novartis 18.97 1.99 Jun/2025
Pacira 23.09 5.46 Jun/2025
Perrigo 49.7 2.52K Jun/2025
Pfizer 9.12 8.86 Jun/2025
Prestige Brands 16.64 3.54 Jun/2025
Roche Holding 19.32 1.87 Jun/2024
Sanofi 16.47 6.85 Jun/2025
Sanofi 16.51 9.31 Jun/2025
Supernus Pharmaceuticals 22.02 2.92 Jun/2025
Zoetis 25.94 2.65 Jun/2025